跳至主要内容
临床试验/NCT02823678
NCT02823678Unknown不适用

Using Pancreatic Volumetric to Determine the Onset of Diabetes Mellitus and Postoperative Outcomes After Pancreatectomy

Florida Hospital Tampa Bay Division0 个研究点目标入组 100 人开始时间: 2013年10月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
主要终点
Percent resected volume of pancreas and diabetes development

研究概览

简要总结

This study will enroll 100 patients scheduled to undergo a pancreatectomy.

The primary objective is to develop a scoring system using pancreatic volume measured by CT scan and intraoperative measurements of the pancreas parenchyma to predict the onset of diabetes mellitus after a pancreatectomy. The investigators will also monitor patients with pre-existing diabetes to see if their diabetes worsens or improves.

详细描述

The primary objective is to develop a scoring system using pancreatic volume measured by CT scan and intraoperative measurements of the pancreas parenchyma to predict the onset of diabetes mellitus after a pancreatectomy. The investigators will also monitor patients with pre-existing diabetes to see if their diabetes worsens or improves. Patients will be followed up to one year to track their diabetes status, postoperative outcomes and quality of life.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients undergoing pancreatectomy at our institution (e.g., pancreaticoduodenectomy, distal pancreatectomy, distal pancreatectomy and splenectomy, central pancreatectomy).

排除标准

  • All patients who are on steroids or other medications whose potential side effects include development of diabetes mellitus or elevated blood glucose.
  • Pregnant or nursing women.
  • Patients with uncontrolled diabetes (HbA1c >8%).

结局指标

主要结局

Percent resected volume of pancreas and diabetes development

时间窗: Postoperative up to one year

次要结局

  • Blood glucose control(Postoperative up to one year)
  • QLQ-C30 Quality of Life Health Questionnaire(Postoperative up to one year)

研究者

发起方
Florida Hospital Tampa Bay Division
申办方类型
Other
责任方
Principal Investigator
主要研究者

Alexander Rosemurgy

Chief of General Surgery

Florida Hospital Tampa Bay Division

相似试验